Embolic compositions and methods
US-2024342338-A1 · Oct 17, 2024 · US
US9717807B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9717807-B2 |
| Application number | US-201314402214-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 13, 2013 |
| Priority date | May 23, 2012 |
| Publication date | Aug 1, 2017 |
| Grant date | Aug 1, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a CT contrast agent for detecting a thrombus, comprising fibrin-targeted peptide sequence-conjugated glycol chitosan-gold nanoparticles. The CT contrast agent for detecting a thrombus according to an embodiment of the present invention may allow rapid and repeated acquisition of CT image information related to the size and location of a thrombus in cardio-cerebral vascular thrombosis, and also enables the imaging monitoring of cerebral thrombus.
Opening claim text (preview).
The invention claimed is: 1. A CT contrast agent for detecting a thrombus, comprising a glycol chitosan-gold nanoparticle, to which fibrin-targeted peptide sequences represented by Formula 1 are conjugated; 2. A method of thrombus monitoring using CT imaging, comprising: 1) a step of injecting a CT contrast agent for detecting a thrombus, which comprises glycol chitosan-gold nanoparticles to which fibrin-targeted peptide sequences represented by Formula 1 are conjugated, into an animal but not a human, which has thrombosis; and 2) a step of obtaining a CT image using micro CT; 3. The method of claim 2 , wherein the animal is one type or more selected from the group consisting of dogs, mice, cats, monkeys, sheep, goats, cows, horses, and pigs. 4. The method of claim 2 , wherein the thrombosis is one type or more selected from the group consisting of cerebral thrombosis, cardiovascular thrombosis, and peripheral vascular thrombosis. 5. The method of claim 2 , further comprising a step of 3D-reconstruction of the CT image after step 2).
Tomographic reconstruction from projections · CPC title
Physics · mapped topic
X-ray contrast preparations · CPC title
Surface-modified nanoparticles, e.g. immuno-nanoparticles · CPC title
Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.